A Cancer-Favoring, Engineered Vaccinia Virus for Cholangiocarcinoma.

Saved in:
Bibliographic Details
Title: A Cancer-Favoring, Engineered Vaccinia Virus for Cholangiocarcinoma.
Authors: Yoo SY; BIO-IT Foundry Technology Institute, Pusan National University, Busan 46241, Korea.; Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50612, Korea., Badrinath N; Biomedical Sciences, School of Medicine, Pusan National University, Yangsan 50612, Korea., Lee HL; Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50612, Korea., Heo J; Biomedical Sciences, School of Medicine, Pusan National University, Yangsan 50612, Korea., Kang DH; Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50612, Korea.; Biomedical Sciences, School of Medicine, Pusan National University, Yangsan 50612, Korea.
Source: Cancers [Cancers (Basel)] 2019 Oct 27; Vol. 11 (11). Date of Electronic Publication: 2019 Oct 27.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2072-6694
DOI:10.3390/cancers11111667